John Verhoef
- Name
- J. Verhoef
- Telephone
- +31 71 526 4436
- j.verhoef@lumc.nl
- Faculteit Geneeskunde
- LUMC - Medische Faculteit Leiden
- LUMC Facilitair Bedrijf
- Peter W.F., Wees P.J. van der, Verhoef J., Jong Z. de, Bodegom-Vos L. van, Hilberdink W.K.H.A., Fiocco M. & Vliet Vlieland T.P.M. (2013), Postgraduate education to increase adherence to a Dutch physiotherapy practice guideline for hip and knee OA: a randomized controlled trial, Rheumatology 52(2): 368-375.
- Peter WF, van der Wees PJ, Hendriks EJ, de Bie RA, Verhoef J, de Jong Z, van Bodegom-Vos L, Hilberdink WK & Vliet Vlieland TP (2012), Quality Indicators for Physiotherapy Care in Hip and Knee Osteoarthritis: Development and Clinimetric Properties., Musculoskeletal Care.
- Bodegom-Vos, L. van; Verhoef, J.; Dickmann, M.; Kleijn, M.; Vliet, I. van; Hurkmans, E.; Wees, P. van der & Vlieland, T.V. (2012), A qualitative study of barriers to the implementation of a rheumatoid arthritis guideline among generalist and specialist physical therapists., Physical Therapy 92(10): 1292-305.
- Peter, W.F.; Wees, P.J. van der; Verhoef, J.; Jong, Z. de; Bodegom-Vos, L. van; Hilberdink, W.K.H.A.; Fiocco, M. & Vlieland, T.P.M.V. (2012), Postgraduate education to increase adherence to a Dutch physiotherapy practice guideline for hip and knee OA: a randomized controlled trial., Rheumatology.
- Hurkmans EJ, Li L, Verhoef J & Vliet Vlieland TP (2012), Physical therapists' management of rheumatoid arthritis: results of a Dutch survey., Musculoskeletal Care 10(3): 142-8.
- Peter W.F.H., Wees P.H. van der, Verhoef J., Jong Z. de, Vos L., Hilberdink W.K.H.A., Fiocco M. & Vliet Vlieland T.P.M. (2011), A Randomised Comparison of Interactive and Conventional Education to Increase Adherence with a Dutch Physical Therapy Practice Guideline for Hip and Knee Osteoarthritis, Arthritis & Rheumatology 63(10): S652-S652.
- (2009), De KNGF-richtlijn Reumatoide artritis (in: Nederlands Tijdschrift voor Reumatologie en Nederlands Tijdschrift voor Fysiotherapie).
- Verhoef J, Toussaint PJ, Putter H, Zwetsloot-Schonk JHM & Vlieland TPMV (2008), Validity and responsiveness of the Rehabilitation Activities Profile (RAP) in patients with rheumatoid arthritis, Clinical Rehabilitation 22(9).
- Verduin PJM, de Bock GH, Vlieland TPMV, Peeters AJ, Verhoef J & Otten W (2008), Purpose in life in patients with rheumatoid arthritis, Clinical Rheumatology 27(7).
- Verhoef J, Toussaint PJ, Putter H, Zwetsloot-Schonk JHM & Vlieland TPMV (2008), The impact of introducing an ICF-based rehabilitation tool on staff satisfaction with multidisciplinary team care in rheumatology: An exploratory study, Clinical Rehabilitation 22(1).
- Verhoef J, Toussaint PJ, Putter H, Zwetsloot-Schonk JHM & Vlieland TPMV (2007), The impact of the implementation of a rehabilitation tool on the contents of the communication during multidisciplinary team conferences in rheumatology, International Journal of Medical Informatics 76(11-12).
- Overberg RI, Alpay LL, Verhoef J & Zwetsloot-Schonk JHM (2007), Illness stories on the Internet: what do breast cancer patients want at the end of treatment?, Psycho-Oncology 16(10).
- Verhoef J, Toussaint PJ, Zwetsloot-Schonk JHM, Breedveld FC, Putter H & Vlieland TPMV (2007), Effectiveness of the introduction of an international classification of functioning, disability and health-based rehabilitation tool in multidisciplinary team care in patients with rheumatoid arthritis, Arthritis and Rheumatism 57(2).
- Amidi M., Romeijn S.G., Verhoef J., Junginger H.E., Bungener L., Huckriede A., Crommelin D.J.A. & Jiskoot W. (2007), N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model, Vaccine 25: 144-153.
- Alpay L.L., Toussaint P.J., Ezendam N.P.M., Rovekamp T., Westendorp R.G.J., Verhoef J. & Zwetsloot-Schonk J.H.M. (2007), The Dutch 'SeniorGezond': an illustration of a road map for the informed patient, Managed Care Magazine (E-zine) 2: 1-11.
- Voorham-van der Zalm PJ, Pelger RCM, Van Heeswijk-Faase IC, Elzevier HW, Ouwerkerk TJ, Verhoef J & Nijeholt GABLA (2006), Placement of probes in electrostimulation and biofeedback training in pelvic floor dysfunction, Acta Obstetricia et Gynecologica Scandinavica 85(7).
- Verhoef J, Toussaint PJ, Putter H, Zwetsloot-Schonk JHM & Vlieland TPMW (2005), Pilot study of the development of a theory-based instrument to evaluate the communication process during multidisciplinary team conferences in rheumatology, International Journal of Medical Informatics 74(10).
- Borchard G., Dorkoosh F.A., Verhoef J., Rafiee-Tehrani M. & Junginger H.E. (2004), A novel peroral peptide drug delivery system based on superporous hydrogel polymers. In: Svenson S. (Ed.), Carrier-based Drug Delivery. Washington: ACS. 296-315.
- Borchard G., Verhoef J., Sarisuta N. & Junginger H.E. (2004), Influence of methylation process on the degree of quarternisation of N-trimethyl chitosan chloride, European Journal of Pharmaceutics and Biopharmaceutics 57: 77-83.
- Verhoef J., Borchard G., Sarisuta N. & Junginger H.E. (2004), In vitro evaluation of intestinal absorption of desmopressin using delivery systems based on superporous hydrogels, 269: 303-310.
- Merwe S. van der, Verhoef J., Verheijden J.H.M., Kotzé A.F. & Junginger H.E. (2004), Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs, European Journal of Pharmaceutics and Biopharmaceutics 58: 225-235.
- Berg M.P. van den, Verhoef J., Romeijn S.G. & Merkus F.W.H.M. (2004), Uptake of estradiol and progesterone into the CSF following intranasal and intravenous delivery in rats, European Journal of Pharmaceutics and Biopharmaceutics 58: 131-135.
- Berg M.P. van den, Merkus P., Romeijn S.G., Verhoef J. & Merkus F.W.H.M. (2004), Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study, PHARMACEUTICAL RESEARCH 21: 799-802.
- Lubben I.M. van der, Kersten G., Fretz M.M., Beuvery C., Verhoef J. & Junginger H.E. (2003), Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice, Vaccine 21: 1400-1408.
- Berg M.P. van den, Merkus P., Romeijn S.G., Verhoef J. & Merkus F.W.H.M. (2003), Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans, Journal of Drug Targeting 11: 325-331.
- Toussaint P.J., Verhoef J., Vliet Vlieland T.P.M. & Zwetsloot-Schonk J.H.M. (2003), Improving the Quality of Communication in Health Care, Proceedings MIE2003 : 857-862.
- Deneer V.H.M., Drese G.B., Roemelé P.E.H., Verhoef J., Lie-A-Huen L., Kingma J.H., Brouwers J.R.B.J. & Junginger H.E. (2002), Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state, 241: 127-134.
- Lubben I.M. van der, Fretz M.M., Opdorp F.A.C., Verhoef J. & Junginger H.E. (2002), Chitosan and trimethyl chitosan microparticles associated with diphtheria toxoid for mucosal vaccination. In: Muzzarelli R.A.A. & Muzzarelli C. (Eds.), Chitosan in Pharmacy and Chemistry. Grottammare: Atec. 109-115.
- Verhoef J., Thanou M.M., Verheijden J.H.M. & Junginger H.E. (2002), Chitosan derivatives as safe and effective absorption enhancers for oral delivery of macromolecular drugs. In: Muzzarelli R.A.A. & Muzzarelli C. (Eds.), Chitosan in Pharmacy and Chemistry. Grottammare: Atec. 51-56.
- Dorkoosh F.A., Setyaningsih D., Borchard G., Rafiee-Tehrani M., Verhoef J. & Junginger H.E. (2002), Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers, 241: 35-41.
- Dorkoosh F.A., Borchard G., Rafiee-Tehrani M., Verhoef J. & Junginger H.E. (2002), Evaluation of superporous hydrogel (SPH) and SPH composite in porcine testine ex- vivo: assessment of drug transport, morphology effect, and mechanical fixation to intestinal wall, European Journal of Pharmaceutics and Biopharmaceutics 53: 161-166.
- Dorkoosh F.A., Verhoef J., Borchard G., Rafiee-Tehrani M., Verheijden J.H.M. & Junginger H.E. (2002), Intestinal absorption of human insuline in pigs using delivery systems based on perporous hydrogel polymers, 247: 47-55.
- Junginger H.E., Thanou M.M. & Verhoef J. (2002), Mucoadhesive hydrogels in drug delivery. In: Swarbrick J. & Boylan J.C. (Eds.), Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker. 1848-1863.
- Dessel H. van, Kamp-Hopmans T.E.M., Fluit A.C., Brisse S., Smet M. de, Dijkshoorn L., Troelstra A., Verhoef J. & Mascini E.M. (2002), Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive unit, Journal of Hospital Infection 51: 89-95.
- Dorkoosh F.A., Verhoef J., Verheijden J.H.M., Rafiee-Tehrani M., Borchard G. & Junginger H.E. (2002), Peroral absorption of octreotide in pigs formulated in delivery systems based on superporous hydrogel polymers, PHARMACEUTICAL RESEARCH 19: 1532-1536.
- Dorkoosh F.A., Verhoef J., Ambagts M.H.C., Rafiee-Tehrani M., Borchard G. & Junginger H.E. (2002), Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin, European Journal of Pharmacology 15: 433-439.
- Dorkoosh F.A., Verhoef J., Rafiee-Tehrani M., Borchard G. & Juninger H.E. (2002), Peroral drug delivery systems for peptides and protein, STP PHARMA SCIENCES 12: 213-221.
- Berg M.P. van den, Romeijn S.G., Verhoef J. & Merkus F.W.H.M. (2002), Serial cerebrospinal fluid sampling in a rat model to study drug uptake form the nasal cavity, Journal of Neuroscience Methods 116: 99-107.
- Lubben I.M. van der, Verhoef J., Fretz M.M., Opdorp F.A.C., Mesu I., Kersten G. & Junginger H.E. (2002), Trimethyl chitosan chloride (TMC) as novel excipient for oral, STP PHARMA SCIENCES 12: 235-242.
- Berg M.P. van den, Verhoef J., Romeijn S.G. & Merkus F.W.H.M. (2002), Uptake of hydrocortisone into the cererbospinal fluid of rats: comparison of intranasal and intravenous administration in the same animal, STP PHARMA SCIENCES 12: 251-255.
- Kotzé A.F., Luessen H.L., Thanou M.M., Verhoef J., Lehr C.M., Boer A.G. de & Junginger H.E. (1999), Chitosan derivatives as absorption enhancers for peptide drugs across mucosal epithelia. In: Mathiowitz E., Lehr C.M. & Chickering D. (Eds.), Bioadhesion in Drug Delivery -Issues in Fundamentals, Novel Approaches and Development. New York, USA: Marcel Dekker.
- Merkus F.W.H.M., Verhoef J., Marttin E., Romeijn S.G., Kuy P.H.M. van der, Hermens W.A.J.J. & Schipper N.G.M. (1999), Cyclodextrins in nasal drug delivery, Advanced Drug Delivery Reviews 36: 41-47.
- Thanou M.M., Kotzé A.F., Scharringhausen T., Luessen H.L., Boer A.G. de, Verhoef J. & Junginger H.E. (1999), Effect of the degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers, JOURNAL OF CONTROLLED RELEASE : .
- Kotzé A.F., Thanou M.M., Luessen H.L., Boer A.G. de, Verhoef J. & Junginger H.E. (1999), Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments, JOURNAL OF PHARMACEUTICAL SCIENCES 88(2): 253-257.
- Luessen H.L., Verhoef J., Leeuw B.J. de, Borchard G., Lehr C.M., Boer A.G. de & Junginger H.E. (1999), Multifunctional polymers for the peroral delivery of peptide drugs. In: Mathiowitz E., Lehr C.M. & Chickering D. (Eds.), Bioadhesion in Drug Delivery - Issues in Fundamentals, Novel Approaches and Development. New York, USA: Marcel Dekker. 299-339.
- Marttin E., Verhoef J., Spies F., Meulen J. van der, Nagelkerke J.F., Koerten H.K. & Merkus F.W.H.M. (1999), The effect of methylated ß-cyclodextrins on the tight junctions of the rat nasal respirato-ry epithelium. Electron microscopic and confocal laser scanning microscopic visualization studies, JOURNAL OF CONTROLLED RELEASE 57: 205-213.
- Boek W.M., Romeijn S.G., Graamans K., Verhoef J., Merkus F.W.H.M. & Huizing E.H. (1999), Validation of animal experiments on ciliary function in vitro. II. The influence of absorption enhancers, preservatives and physiological saline, Acta Oto-laryngologica 119: 98-101.
- Boek W.M., Romeijn S.G., Graamans K., Verhoef J., Merkus F.W.H.M. & Huizing E.H. (1999), Validation of animal experiments on ciliary function in vitro. I. The influence of substances used clinically, Acta Oto-laryngologica 119: 93-97.
- Orendi J.M., Bloem A.C., Borleffs J.C.C., Wijnholds F.J., Vos N.M. de, Nottet H.S.L.M., Viser M.R., Snippe H., Verhoef J. & Boucher C.A.B. (1998), Activation and cell cycle antigens in CD 4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection, The Journal of Infectious Diseases 178: 1279-1287.
- Kotzé A.F., Luessen H.L., Boer A.G. de, Verhoef J. & Junginger H.E. (1998), Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments, European Journal of Pharmaceutical Sciences 7: 145-151.
- Kotzé A.F., Luessen H.L., Leeuw B.J. de, Boer A.G. de, Verhoef J. & Junginger H.E. (1998), Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2), JOURNAL OF CONTROLLED RELEASE 51: 35-46.
- Verhoef J. (1998), Development of suitable dosage forms for drug delivery. Total Quality Assurance and Quality Management. Delft, The Netherlands. [lecture].
- Merkus F.W.H.M., Kuy P.H.M. van der, Marttin E., Romeijn S.G. & Verhoef J. (1998), Efficacy and safety of cyclodextrins in nasal drug delivery. In: , Proceedings of the 9th Int.Symp. of Cyclodextrins. Dordrecht, NL: Kluwer Academic Publishers.
- Marttin E., Verhoef J. & Merkus F.W.H.M. (1998), Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs, Journal of Drug Targeting 6: 17-36.
- Junginger H.E. & Verhoef J. (1998), Macromolecules as safe penetration enhancers for hydrophilic drugs - a fiction?, Pharmaceutical Sciences and Technology Today 1: 370-376.
- Junginger H.E., Luessen H.L. & Verhoef J. (1998), Multifunctional polymers as safe penetration enhancers for peroral peptide delivery and absorption. In: Frokjaer S., Christrup L. & Krogsgaard-Larsen P. (Eds.), Peptide and Protein Drug Delivery. Copenhagen, Denmark: Munksgaard. 187-201.
- Marttin E., Schipper N.G.M., Verhoef J. & Merkus F.W.H.M. (1998), Nasal mucociliary clearance as a factor in nasal drug delivery, Advanced Drug Delivery Reviews 29: 13-38.
- Thanou M.M., Sieval A.B., Kotzé A.F., Boer A.G. de, Verhoef J. & Junginger H.E. (1998), N, N, N-trimethyl chitosan chloride (TMC) of high degree of substitution as a potential enhancer for hydrophilic drugs. In: Domard A., Roberts G.A.F. & Varum K.M. (Eds.), Advances in Chitin Sciences. Lyon, France 384-389.
- Sieval A.B., Thanou M.M., Kotzé A.F., Verhoef J., Brussee J. & Junginger H.E. (1998), Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride, Carbohydrate Polymers 36: 157-165.
- Verhoef J. (1998), Safe absorption enhancers for peptide drug delivery. IBC Drug Delivery Systems. London, UK. [lecture].